...
首页> 外文期刊>World Journal of Cardiovascular Diseases >Use of Subcutaneous Port Catheter in Childhood Malignancies
【24h】

Use of Subcutaneous Port Catheter in Childhood Malignancies

机译:皮下开口导管在儿童恶性肿瘤中的应用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The port catheters are used to give long-term total parenteral nutrition, intravenous fluids, blood and blood products, or to be preferred for oncology and hematological diseases. In this study, we sought to review our results concerning the subcutaneous port catheter appliance in childhood malignancies. Methods: Two hundred ten subcutaneous port catheters applied to 192 patients between November 2010 and October 2015 were examined retrospectively in a cross- sectional study. Information such as demographic data, primary diagnoses, port types and implantation durations were recorded. Localization of the intervention, surgical technique, early and late complications and causes of port removal were evaluated. Results: Mean age of patients was 6.4 ± 4.9 years (1 month - 17 years), 77 (40.1%) were female and 115 (59.9%) male. One hundred twenty nine ports were inserted from the right internal jugular vein, 59 to right subclavian vein, 14 to left subclavian vein and 8 to left internal jugular vein. Total duration of implantation was 55,492 days and median duration was 289 days. Early complications were: 1 (0.5%) hemothorax, 1 (0.5%) pneumothorax, 1 (0.5%) carotid artery injury, 1 (0.5%) arrhythmia and in 2 (1%) cases port mal-positioning. Late complications were: 9 (4.3%) infection and 8 (3.8%) mechanical problems, 7 (3.3%) thrombosis, and in 1 (0.5%) port fracture was detected. Port catheter was removed in 18 (8.6%) cases. No significant difference was found when jugular and subclavian vein implantation was compared in terms of all complications, especially infection and thrombosis. Conclusion: Use of port catheter is a safe option in children who are receiving a long-term chemotherapy. Education of the medical team will diminish the complication rate in port catheter insertions.
机译:背景:端口导管用于提供长期的全胃肠外营养,静脉输液,血液和血液制品,或者是肿瘤和血液系统疾病的首选。在这项研究中,我们试图回顾我们关于儿童恶性肿瘤中皮下端口导管矫治器的研究结果。方法:在一项横断面研究中,回顾性研究了2010年11月至2015年10月间对192例患者应用的260个皮下端口导管。记录诸如人口统计数据,主要诊断,端口类型和植入持续时间之类的信息。评估了干预措施,手术技术,早期和晚期并发症以及端口切除的原因。结果:患者的平均年龄为6.4±4.9岁(1个月至17岁),女性77例(40.1%),男性115例(59.9%)。右颈内静脉插入129个端口,右锁骨下静脉插入59个端口,左锁骨下静脉插入14个端口,左颈内静脉插入8个端口。植入的总时间为55492天,中位时间为289天。早期并发症为:1(0.5%)血胸,1(0.5%)气胸,1(0.5%)颈动脉损伤,1(0.5%)心律失常和2(1%)例端口定位不良。晚期并发症为:9例(4.3%)感染和8例(3.8%)的机械问题,7例(3.3%)的血栓形成以及1例(0.5%)的端口破裂。 18例(8.6%)的患者中拔出了导管。比较颈椎和锁骨下静脉植入的所有并发症,尤其是感染和血栓形成,无显着差异。结论:对于接受长期化疗的儿童,使用端口导管是一种安全的选择。对医疗团队的教育将减少端口导管插入的并发症发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号